Cargando…

Dermatomyositis with positive anti‐TIF1 gamma antibodies in an adult female: A case report

Dermatomyositis is an uncommon autoimmune disease with only few cases reported from Nepal. Presence of anti TIF‐1 gamma antibodies in DM are the strongest predictor of malignancy. Timely screening of malignancies for early detection and management remains the mainstay of this report.

Detalles Bibliográficos
Autores principales:	Adhikari, Krishna, Pant, Prashant, Bhandari, Sanjeev, Paudel, Sandip, Poudyal, Buddhi, Sharma, Lucky, Sigdel, Keshav Raj, Subedi, Rojina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660285/ https://www.ncbi.nlm.nih.gov/pubmed/38028105 http://dx.doi.org/10.1002/ccr3.8215

Ejemplares similares

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
por: Lerman, Irina, et al.
Publicado: (2019)

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
por: Ferronato, Marco, et al.
Publicado: (2023)

Case Report: Pulmonary tuberculosis and raised transaminases without pre-existing liver disease- Do we need to modify the antitubercular therapy?
por: Gautam, Sanjeev, et al.
Publicado: (2020)

Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis
por: TAKEZAKI, Daiki, et al.
Publicado: (2020)

Case Report: Gastric Mucormycosis- a rare but important differential diagnosis of upper gastrointestinal bleeding in an area of Helicobacter pylori endemicity
por: Adhikari, Sudeep, et al.
Publicado: (2019)

Adverse events with ayurvedic medicines- possible adulteration and some inherent toxicities
por: Paudyal, Buddhi, et al.
Publicado: (2019)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis
por: Selickaja, Sandra, et al.
Publicado: (2022)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Case Report: Co-existence of sarcoidosis and Takayasu arteritis
por: Poudel, Jiwan, et al.
Publicado: (2020)

A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma
por: Dziwis, Jennifer, et al.
Publicado: (2019)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Poor communication by health care professionals may lead to life-threatening complications: examples from two case reports
por: Tiwary, Abhishek, et al.
Publicado: (2019)

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
por: Wu, Chih-Feng, et al.
Publicado: (2023)

NanoString technology distinguishes anti‐TIF‐1γ(+) from anti‐Mi‐2(+) dermatomyositis patients
por: Preusse, Corinna, et al.
Publicado: (2021)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
por: Tomita, Natsuo, et al.
Publicado: (2021)

Case Report: Cryptococcal meningitis in an apparently immunocompetent patient in Nepal - challenges in diagnosis and treatment
por: Jha, Ashish, et al.
Publicado: (2019)

Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
por: Ono, Ryohei, et al.
Publicado: (2021)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
por: Imai, Ryosuke, et al.
Publicado: (2021)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
por: Parkes, Joanna E., et al.
Publicado: (2018)

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker”: A case report
por: Karino, Kohei, et al.
Publicado: (2018)

Tracker ready for transport at TIF
por: Hoch, Michael
Publicado: (2007)

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report
por: Kubeček, Ondřej, et al.
Publicado: (2016)

The CMS Tracker support tube in the TIF.
por: Michael Eppard
Publicado: (2005)

Transport of the Tracker from TIF to CMS
por: Hoch, Michael
Publicado: (2007)

The evolution of TIF: transoral incisionless fundoplication
por: Ihde, Glenn M.
Publicado: (2020)

The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019)

A case of dermatomyositis with anti-TIF1γ antibodies revealing isolated para-aortic lymphadenopathy metastatic recurrence of endometrial cancer: A case report
por: Lim, Darosa, et al.
Publicado: (2020)

Images of the CMS Tracker Integration Facility (TIF)
por: Eppard, M
Publicado: (2008)

Diseño de prototipo de rastro "TIF"
por: Altamirano Juárez, Rosa Laura
Publicado: (2009)

TIF1 Proteins in Genome Stability and Cancer
por: McAvera, Roisin M., et al.
Publicado: (2020)

MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2
por: Yin, Hong, et al.
Publicado: (2007)

Estimation of leisure time physical activity and sedentary behaviour among school adolescents in Nepal
por: Paudel, Susan, et al.
Publicado: (2014)

The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
por: Zarkavelis, George, et al.
Publicado: (2020)

Medical abortion drug dispensing practices among private pharmacy workers in Nepal: A mystery client study
por: Sigdel, Anil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fhn0lb51b8u4rdu1rqigurj4nl